120 related articles for article (PubMed ID: 14729634)
1. In vivo imaging of HIV protease activity in amplicon vector-transduced gliomas.
Shah K; Tung CH; Chang CH; Slootweg E; O'Loughlin T; Breakefield XO; Weissleder R
Cancer Res; 2004 Jan; 64(1):273-8. PubMed ID: 14729634
[TBL] [Abstract][Full Text] [Related]
2. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
Herrlinger U; Jacobs A; Quinones A; Woiciechowsky C; Sena-Esteves M; Rainov NG; Fraefel C; Breakefield XO
Hum Gene Ther; 2000 Jul; 11(10):1429-38. PubMed ID: 10910140
[TBL] [Abstract][Full Text] [Related]
3. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
[TBL] [Abstract][Full Text] [Related]
4. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.
Shah K; Tang Y; Breakefield X; Weissleder R
Oncogene; 2003 Oct; 22(44):6865-72. PubMed ID: 14534533
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
6. A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells.
Kinoshita Y; Kamitani H; Mamun MH; Wasita B; Kazuki Y; Hiratsuka M; Oshimura M; Watanabe T
Neurol Res; 2010 May; 32(4):429-37. PubMed ID: 19589205
[TBL] [Abstract][Full Text] [Related]
7. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
[TBL] [Abstract][Full Text] [Related]
8. HIV protease as a target for retrovirus vector-mediated gene therapy.
Todd S; Anderson C; Jolly DJ; Craik CS
Biochim Biophys Acta; 2000 Mar; 1477(1-2):168-88. PubMed ID: 10708857
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects on human melanoma xenografts of an amplicon vector transducing the herpes thymidine kinase gene followed by ganciclovir.
Wang S; Qi J; Smith M; Link CJ
Cancer Gene Ther; 2002 Jan; 9(1):1-8. PubMed ID: 11916238
[TBL] [Abstract][Full Text] [Related]
10. A modular system to evaluate the efficacy of protease inhibitors against HIV-2.
Mahdi M; Matúz K; Tóth F; Tőzsér J
PLoS One; 2014; 9(11):e113221. PubMed ID: 25419967
[TBL] [Abstract][Full Text] [Related]
11. Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapy.
Hoshi M; Harada A; Kawase T; Uyemura K; Yazaki T
Cancer Gene Ther; 2000 May; 7(5):799-805. PubMed ID: 10830727
[TBL] [Abstract][Full Text] [Related]
12. Characterization of antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICPo protein.
Cuchet D; Ferrera R; Lomonte P; Epstein AL
J Gene Med; 2005 Sep; 7(9):1187-99. PubMed ID: 15852412
[TBL] [Abstract][Full Text] [Related]
13. Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli.
Dautin N; Karimova G; Ullmann A; Ladant D
J Bacteriol; 2000 Dec; 182(24):7060-6. PubMed ID: 11092869
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antitumoral properties of the protease inhibitor indinavir in a murine model of hepatocarcinoma.
Esposito V; Palescandolo E; Spugnini EP; Montesarchio V; De Luca A; Cardillo I; Cortese G; Baldi A; Chirianni A
Clin Cancer Res; 2006 Apr; 12(8):2634-9. PubMed ID: 16638877
[TBL] [Abstract][Full Text] [Related]
15. A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors.
Pechan PA; Fotaki M; Thompson RL; Dunn R; Chase M; Chiocca EA; Breakefield XO
Hum Gene Ther; 1996 Oct; 7(16):2003-13. PubMed ID: 8930661
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic activity of human immunodeficiency virus type 1 protease heterologous fusion proteins in mammalian cells.
Arrigo SJ; Haines JK; Huffman KM
DNA Cell Biol; 1995 Jan; 14(1):15-23. PubMed ID: 7832989
[TBL] [Abstract][Full Text] [Related]
17. Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vector.
Ho IA; Hui KM; Lam PY
Hum Gene Ther; 2004 May; 15(5):495-508. PubMed ID: 15144579
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization.
Koh Y; Matsumi S; Das D; Amano M; Davis DA; Li J; Leschenko S; Baldridge A; Shioda T; Yarchoan R; Ghosh AK; Mitsuya H
J Biol Chem; 2007 Sep; 282(39):28709-28720. PubMed ID: 17635930
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.
Zhang YM; Imamichi H; Imamichi T; Lane HC; Falloon J; Vasudevachari MB; Salzman NP
J Virol; 1997 Sep; 71(9):6662-70. PubMed ID: 9261388
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]